Clinical Trial Update: Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour) [Phase 2]

View source ↗

Summary

Phase 2 trial of vorinostat, bortezomib, and dexamethasone in multiple myeloma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Leeds | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED